The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease.

The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease. Abstract Text:

OBJECTIVES: To examine the cost-effectiveness of a randomized, clinical trial of a home-based intervention for caregivers of people with dementia. DESIGN: This cost-effectiveness analysis examined Resources for Enhancing Alzheimer's Caregivers Health (REACH II), a multisite, randomized, clinical trial, from June 2002 through December 2004, funded by the National Institute on Aging and the National Institute of Nursing Research, of a behavioral intervention to decrease caregivers' stress and improve management of care recipient behavioral problems. SETTING: Community-dwelling dementia caregiving dyads from the Memphis REACH II site. PARTICIPANTS: Of Memphis' random sample of 55 intervention and 57 control black and white dyads, 46 in each arm completed without death or discontinuation. Family caregivers were aged 21 and older, lived with the care recipient, and had provided 4 or more hours of care per day for 6 months or longer. Care recipients were cognitively and functionally impaired. INTERVENTION(S): Twelve individual sessions (9 home sessions and 3 telephone sessions) supplemented by five telephone support-group sessions. Control caregivers received two "check in" phone calls. MEASUREMENTS: Incremental cost-effectiveness ratio (ICER), the additional cost to bring about one additional unit of benefit (hours per day of providing care). RESULTS: At 6 months, there was a significant difference between intervention caregivers and control caregivers in hours providing care (P=.01). The ICER showed that intervention caregivers had 1 extra hour per day not spent in caregiving, at a cost of $5 per day. CONCLUSION: The intervention provided that most scarce of caregiver commodities--time. The emotional and physical costs of dementia caregiving are enormous, and this intervention was able to alleviate some of that cost.

The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Journal of the American Geriatrics Society

VOLUME: 56

Page Numbers: 413-20

Journal Abbreviation:

ISSN: 1532-5415

DAY: 27

MONTH: 12

YEAR: 2007

The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7503062

The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease.

AFFILIATION: Veterans Affairs Medical Center Memphis, Memphis, Tennessee 38104, USA. linda.nichols@va.gov

Country: United States

AGENCY: United States NIA

GRANT: U01-AG13313

ACRONYM: AG

MEDLINETA: J Am Geriatr Soc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease Related Publications

• A prospective investigation of major depressive disorder and comorbidity in abused and neglected children grown up.
• Age differences in life satisfaction as a function of discrepancy between real and ideal self concepts.
• Autoimmune liver disease.
• CNS lymphomatoid granulomatosis in AIDS: CT and MR appearances.
• Cell signaling in oxidative stress-induced liver injury.
• Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly.
• Compensatory mechanisms and the type of injury determine the fate of cells with impaired macroautophagy.
• Employment opportunities for older adults: engineering design and research issues.
• Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease.
• Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis.
• Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis.
• HLA DQ gene dosage and risk and severity of celiac disease.
• Loss of macroautophagy promotes or prevents fibroblast apoptosis depending on the death stimulus.
• Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis.
• Regulation of hepatocyte apoptosis by oxidative stress.
• Safety issues in the management of autoimmune hepatitis.
• The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease.
• [Binge eating and obesity in children]
• [Statistical analysis of some size parameters of haversian systems in femoral, ground transverse sections in man and animals (author's transl)]